Elevated Cortisol Symptoms: Labs, Diagnosis, and Next Steps

Why Cortisol Becomes Elevated

Cortisol is produced by the adrenal glands under tight regulation by the hypothalamic-pituitary-adrenal (HPA) axis. When this feedback loop is disrupted or overridden, cortisol output rises and stays elevated, producing a constellation of symptoms that can mimic dozens of other conditions.

The single most common reason for elevated cortisol is exogenous glucocorticoid use. Prednisone, dexamethasone, inhaled fluticasone at high doses, and even topical betamethasone applied to large skin areas can suppress the HPA axis and simultaneously raise circulating cortisol metabolites [1]. The Endocrine Society's 2008 clinical practice guideline (updated 2015) recommends screening for Cushing syndrome only after iatrogenic sources have been excluded [2].

Endogenous hypercortisolism divides into ACTH-dependent and ACTH-independent causes. Pituitary corticotroph adenomas (Cushing disease) account for approximately 70% of endogenous cases, ectopic ACTH secretion from small-cell lung carcinoma or bronchial carcinoids accounts for 10-15%, and adrenal adenomas or carcinomas cause most of the remainder [3]. A 2021 retrospective cohort published in the Journal of Clinical Endocrinology & Metabolism (N=753) found that the median time from symptom onset to diagnosis of Cushing syndrome was 34 months, highlighting how easily the signs are attributed to other conditions [4].

Chronic psychological stress does raise cortisol. But the magnitude differs from pathological hypercortisolism by an order of magnitude. Stress-related cortisol elevations rarely exceed 25 mcg/dL at their peak, while untreated Cushing syndrome routinely produces 24-hour urinary free cortisol values three to four times the upper limit of normal [5].

Recognizing the Symptom Pattern

The textbook presentation of hypercortisolism includes central adiposity, moon facies, dorsocervical fat pad, wide purple striae, and proximal muscle weakness. That pattern is real but often incomplete.

Many patients present with only two or three features. A 2019 analysis in Clinical Endocrinology found that 41% of confirmed Cushing syndrome patients initially presented with isolated weight gain and fatigue as their only complaints [6]. The 2008 Endocrine Society guideline, authored by Dr. Lynnette Nieman and colleagues, states: "Testing should be performed in patients with multiple and progressive features, especially those that are more predictive of Cushing syndrome" [2]. Progressive means the symptoms worsen over months. A patient who develops new-onset hypertension, unexplained hyperglycemia, and easy bruising over 6-12 months warrants screening more than someone with stable, longstanding obesity.

Skin findings carry high diagnostic specificity. Wide (greater than 1 cm) violaceous striae on the abdomen, thighs, or axillae have a positive likelihood ratio above 5 for Cushing syndrome. Thin skin, delayed wound healing, and spontaneous ecchymoses also point toward cortisol excess rather than simple metabolic syndrome [7].

Psychiatric symptoms are common and underappreciated. Depression occurs in 50-80% of Cushing syndrome patients, and cognitive impairment, particularly short-term memory deficits, has been documented on neuropsychological testing even in subclinical hypercortisolism [8].

The Three First-Line Screening Tests

The Endocrine Society recommends choosing from three validated screening tests. No single test is sufficient on its own. Two abnormal results from different assays are required to confirm the biochemical diagnosis [2].

Late-night salivary cortisol measures free cortisol at the circadian nadir (typically collected at 11 PM). Normal cortisol drops to its lowest point late at night. In Cushing syndrome, this nadir is lost. A meta-analysis of 17 studies (N=2,237) published in the Journal of Clinical Endocrinology & Metabolism found pooled sensitivity of 92% and specificity of 96% for late-night salivary cortisol in diagnosing Cushing syndrome [9]. The test requires two separate collections on different nights. Patients must avoid licorice, tobacco, and oral contamination with blood for accurate results.

24-hour urinary free cortisol (UFC) captures total cortisol excretion over a full day, smoothing out pulsatile secretion. Values exceeding three to four times the upper limit of normal are highly specific for Cushing syndrome. Values between one and three times the upper limit sit in a gray zone and require additional testing. A single elevated collection is not diagnostic. The Endocrine Society guideline recommends at least two 24-hour collections [2].

1 mg overnight dexamethasone suppression test (DST) exploits the negative feedback loop. A healthy HPA axis suppresses morning cortisol to <1.8 mcg/dL (50 nmol/L) after 1 mg dexamethasone taken at 11 PM the prior night. Failure to suppress suggests autonomous cortisol production. Sensitivity is approximately 95%, but specificity is lower (around 80%), generating false positives in patients with depression, alcoholism, obesity, or those taking estrogen-containing oral contraceptives (which raise cortisol-binding globulin and total cortisol) [10].

Interpreting Your Lab Results

A single normal screening test does not exclude hypercortisolism if clinical suspicion is high. False negatives occur. Cyclic Cushing syndrome, where cortisol secretion waxes and wanes over weeks to months, can produce normal results on any given test day.

Conversely, false positives are frequent in specific populations. Dr. Lynnette Nieman, senior investigator at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, has noted: "Pseudo-Cushing states, particularly major depressive disorder and alcohol use disorder, can produce biochemical results indistinguishable from mild Cushing syndrome on first-line tests" [11]. The dexamethasone-CRH test helps differentiate pseudo-Cushing from true Cushing syndrome in these gray-zone cases.

If both first-line tests are normal and clinical suspicion persists, repeat testing in 3-6 months is appropriate. If two different first-line tests return abnormal values, the next step is plasma ACTH measurement to classify the hypercortisolism as ACTH-dependent or ACTH-independent [2].

Morning ACTH <5 pg/mL with elevated cortisol points to an adrenal source (adenoma, carcinoma, or bilateral macronodular adrenal hyperplasia). ACTH in the normal-to-elevated range (>20 pg/mL) suggests a pituitary or ectopic ACTH-secreting tumor. Values between 5 and 20 pg/mL are indeterminate and require dynamic testing such as CRH stimulation [3].

Imaging and Localization

Imaging follows biochemistry. Ordering an MRI or CT scan before confirming biochemical hypercortisolism leads to incidental findings (adrenal incidentalomas appear in 4-7% of abdominal CT scans in the general population) that complicate rather than clarify the picture [12].

For ACTH-dependent Cushing syndrome, pituitary MRI with gadolinium contrast is the standard first imaging study. Pituitary microadenomas causing Cushing disease are often small (under 6 mm), and MRI detects them in only about 50-60% of confirmed cases [13]. When MRI is negative or equivocal, bilateral inferior petrosal sinus sampling (BIPSS) with CRH stimulation distinguishes pituitary from ectopic ACTH secretion with sensitivity and specificity both exceeding 95% [14].

For ACTH-independent disease, adrenal CT (non-contrast, thin-cut) is the imaging modality of choice. Adrenal adenomas typically show low attenuation (<10 Hounsfield units), while adrenal carcinomas tend to be larger (>4 cm), irregularly shaped, and higher in attenuation [15].

Common Causes People Miss

Several medications beyond obvious glucocorticoids can raise cortisol or interfere with cortisol testing. Oral estrogen (including combined oral contraceptives) raises cortisol-binding globulin, which increases total serum cortisol without increasing free cortisol. This produces a false-positive on the 1 mg DST in up to 50% of women taking estrogen-containing pills [10]. Salivary and urinary free cortisol are unaffected and should be used instead.

Megestrol acetate, a synthetic progestin used as an appetite stimulant, has intrinsic glucocorticoid activity and can cause iatrogenic Cushing syndrome. Ketoconazole, sometimes used to treat hypercortisolism itself, can alter cortisol metabolism and confound testing. Phenytoin and carbamazepine accelerate dexamethasone metabolism through CYP3A4 induction, reducing the effective dose of the DST and causing false-positive non-suppression [2].

Obstructive sleep apnea disrupts the cortisol circadian rhythm and can raise late-night salivary cortisol. A 2018 study in Sleep Medicine (N=312) demonstrated that 23% of patients with severe OSA had at least one abnormal late-night salivary cortisol result that normalized after 3 months of CPAP therapy [16].

When to See an Endocrinologist

Not every mildly elevated cortisol result demands subspecialty referral. A single borderline late-night salivary cortisol in an otherwise healthy individual with no Cushingoid features can be repeated in 4-6 weeks. Primary care physicians can order and interpret first-line screening tests.

Referral becomes necessary when two different screening tests are abnormal, when there is clinical progression (new hypertension, new diabetes, worsening proximal weakness), or when the patient has an adrenal incidentaloma with biochemical evidence of cortisol autonomy [2]. The European Society of Endocrinology's 2016 guideline on adrenal incidentalomas recommends the 1 mg DST as the preferred screening test for autonomous cortisol secretion in patients with incidentally discovered adrenal masses, using a post-dex cortisol cutoff of <1.8 mcg/dL [17].

Pediatric patients with growth arrest plus weight gain, and any patient with an adrenal mass plus biochemical hypercortisolism, should be referred promptly regardless of symptom severity.

Treatment Depends on the Cause

Treatment for confirmed hypercortisolism is cause-specific. Iatrogenic Cushing syndrome resolves with glucocorticoid taper, though HPA axis recovery can take 6-18 months and requires stress-dose hydrocortisone coverage during the recovery period [1].

Pituitary Cushing disease is treated primarily with transsphenoidal surgery. A 2020 systematic review and meta-analysis (48 studies, N=6,400) published in Neurosurgical Focus reported initial remission rates of 78% for microadenomas and 61% for macroadenomas after first surgery [18]. Recurrence occurs in 15-25% of initially remitted patients within 10 years, mandating long-term biochemical surveillance.

For patients who are not surgical candidates or who recur after surgery, medical therapy options include ketoconazole (200-400 mg twice daily), osilodrostat (a newer 11-beta-hydroxylase inhibitor FDA-approved in 2020), metyrapone, and pasireotide. The LINC-3 trial (N=137) demonstrated that osilodrostat normalized urinary free cortisol in 77% of patients at 48 weeks [19].

Bilateral adrenalectomy is a definitive option when other treatments fail, but it commits the patient to lifelong glucocorticoid and mineralocorticoid replacement and carries a 20-30% risk of Nelson syndrome (aggressive corticotroph tumor progression) over 10-20 years if the pituitary source is not addressed [20].

Adrenal adenomas causing ACTH-independent Cushing syndrome are treated with unilateral laparoscopic adrenalectomy, which is curative in over 95% of cases [15].

Monitoring After Treatment

Post-treatment follow-up requires morning serum cortisol, 24-hour UFC, and clinical assessment at 3, 6, and 12 months after surgery, then annually for at least 10 years. The Endocrine Society recommends a morning serum cortisol <2 mcg/dL within 7 days of transsphenoidal surgery as the strongest predictor of long-term remission [2].

HPA axis recovery after successful surgery typically takes 6-18 months. During this period, patients need physiologic hydrocortisone replacement (15-25 mg daily in divided doses) and a medical alert bracelet identifying adrenal insufficiency risk. Recovery is confirmed by a cosyntropin stimulation test showing a peak cortisol >18 mcg/dL [1].

Bone density screening with DXA is recommended at the time of diagnosis and 1-2 years after biochemical remission, as hypercortisolism causes significant bone loss (particularly at the lumbar spine), and fracture risk remains elevated for up to 5 years after cortisol normalization [21]. Patients whose morning serum cortisol remains above 5 mcg/dL at the 6-month post-operative mark should undergo repeat 24-hour UFC and consideration of additional therapy.